Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001352620-26-000002
Filing Date
2026-01-05
Accepted
2026-01-05 16:40:16
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1767649212.html 4  
1 FORM 4 wk-form4_1767649212.xml 4 6401
  Complete submission text file 0001352620-26-000002.txt   7868
Mailing Address GOSSAMER BIO, INC. 3115 MERRYFIELD ROW, SUITE 120 SAN DIEGO CA 92121
Business Address
Hasnain Faheem (Reporting) CIK: 0001352620 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38796 | Film No.: 26507114

Mailing Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121
Business Address 3115 MERRYFIELD ROW SUITE 120 SAN DIEGO CA 92121 (858) 684-1300
Gossamer Bio, Inc. (Issuer) CIK: 0001728117 (see all company filings)

EIN.: 475461709 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)